1. Barankay A, Späth P, Mitto P, Vogt W, Richter JA (1989) Sufentanil-N20/02- bzw. Halothan-N20/02-Anaesthesie bei Operationen an Säuglingen und Kindern mit angeborenen Herzfehlern–Hämodynamik und Plasmakatecholamine. Anästhesist 38: 391–396
2. Castaneda AR, Mayer JE, Jonas RA, Lock JE, Wessel DL, Hickey PR (1989) The neonate with critical congenital heart disease: Repair — a surgical challenge. J Thorac Cardiovasc Surg 98: 869–875
3. Hensley FA, Larach DR, Martin DE, Stauffer R, Waldhausen JA (1987) The effect of halothane/nitrous oxide/oxygen mask induction on arterial hemoglobin saturation in cyanotic heart disease. J Cardiothorac Anesth 1: 289–296
4. Hickey PR, Wessel DL (1987) Anesthesia for treatment of congenital heart disease. In: Kaplan JA (ed) Cardiac anesthesia. Saunders, Philadelphia London Toronto Montreal Sydney Tokyo, pp 635–723
5. Hickey PR, Crone RK (1986) Cardiovascular physiology and pharmacology in children: normal and diseased pediatric cardiovascular systems. In: Ryan JF, Coté CJ, Todres DI, Goudsouzian N (eds) A practice of anesthesia for infants and children. Grune & Stratton, Orlando New York San Diego Boston London San Francisco Tokyo Sydney Toronto, pp 175–193